Home/Filings/4/0001683168-18-000492
4//SEC Filing

Kern Russell 4

Accession 0001683168-18-000492

CIK 0001355790other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 3:33 PM ET

Size

10.9 KB

Accession

0001683168-18-000492

Insider Transaction Report

Form 4
Period: 2018-02-20
Semechkin Rouslan
Director10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2018-02-20$1.09/sh+27,500$29,975169,509 total
  • Exercise/Conversion

    Common Stock

    2018-02-20$1.10/sh+8,889$9,778178,398 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2018-02-2027,50062,500 total
    Exercise: $1.09Exp: 2027-02-10Common Stock (62,500 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2018-02-208,88931,111 total
    Exercise: $1.10Exp: 2027-05-31Common Stock (31,111 underlying)
Footnotes (2)
  • [F1]3/36th of the shares underlying such options shall vest on May 10, 2017, and the remaining share in equal monthly installments over a period of 33 months.
  • [F2]3/36th of the shares underlying such options shall vest on August 31, 2017, and the remaining share in equal monthly installments over a period of 33 months.

Issuer

International Stem Cell CORP

CIK 0001355790

Entity typeother

Related Parties

1
  • filerCIK 0001446397

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 3:33 PM ET
Size
10.9 KB